These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field. Lommerts JE; Teulings HE; Ezzedine K; van Geel N; Hartmann A; Speeckaert R; Spuls PI; Wolkerstorfer A; Luiten RM; Bekkenk MW J Am Acad Dermatol; 2016 Dec; 75(6):1198-1204. PubMed ID: 27717621 [TBL] [Abstract][Full Text] [Related]
3. Melanoma-associated hypopigmentation: where are the antibodies? Merimsky O; Shoenfeld Y; Baharav E; Altomonte M; Chaitchik S; Maio M; Ferrone S; Fishman P Am J Clin Oncol; 1996 Dec; 19(6):613-8. PubMed ID: 8931683 [TBL] [Abstract][Full Text] [Related]
4. Hypopigmented mycosis fungoides: a clinical mimicker of vitiligo. Tolkachjov SN; Comfere NI J Drugs Dermatol; 2015 Feb; 14(2):193-4. PubMed ID: 25689815 [TBL] [Abstract][Full Text] [Related]
5. Segmental vitiligo-like hypopigmentation associated with metastatic melanoma. Cerci FB; Mesquita LA; Silva de Castro CC Cutis; 2017 Jun; 99(6):E1-E2. PubMed ID: 28686764 [No Abstract] [Full Text] [Related]
6. Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders. Mollet I; Ongenae K; Naeyaert JM Dermatol Clin; 2007 Jul; 25(3):363-71, ix. PubMed ID: 17662902 [TBL] [Abstract][Full Text] [Related]
7. Tumor of follicular infundibulum: an unsuspected cause of macular hypopigmentation. Kubba A; Batrani M; Taneja A; Jain V Indian J Dermatol Venereol Leprol; 2014; 80(2):141-4. PubMed ID: 24685851 [TBL] [Abstract][Full Text] [Related]
9. The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma. Michelsen D Med Hypotheses; 2010 Jan; 74(1):67-70. PubMed ID: 19748188 [TBL] [Abstract][Full Text] [Related]
10. The significance of eccentric and central hyperpigmentation, multifocal hyper/hypopigmentation, and the multicomponent pattern in melanocytic lesions lacking specific dermoscopic features of melanoma. Arevalo A; Altamura D; Avramidis M; Blum A; Menzies S Arch Dermatol; 2008 Nov; 144(11):1440-4. PubMed ID: 19015418 [TBL] [Abstract][Full Text] [Related]
11. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo). Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726 [TBL] [Abstract][Full Text] [Related]
14. Application of a pigment measuring device--Mexameter--for the differential diagnosis of vitiligo and nevus depigmentosus. Park ES; Na JI; Kim SO; Huh CH; Youn SW; Park KC Skin Res Technol; 2006 Nov; 12(4):298-302. PubMed ID: 17026663 [TBL] [Abstract][Full Text] [Related]